Levamisole in Illicit Trafficking Cocaine Seized: A One-Year Study

References

• Broseus, J., N. Gentile, F. Bonadio Pont, J. M. Garcia Gongora, L. Gaste, and P. Esseiva. 2015. Qualitative, quantitative and temporal study of cutting agents for cocaine and heroin over 9 years. Forensic Science International 257:307–13. doi:10.1016/j.forsciint.2015.09.014.
   PubMed Web of Science ®Google Scholar
• Broseus, J., N. Gentile, and P. Esseiva. 2016. The cutting of cocaine and heroin: A critical review. Forensic Science International 262:73–83. doi:10.1016/j.forsciint.2016.02.033.
   PubMed Web of Science ®Google Scholar
• Broseus, J., S. Huhtala, and P. Esseiva. 2015. First systematic chemical profiling of cocaine police seizures in Finland in the framework of an intelligence-led approach. Forensic Science International 251:87–94. doi:10.1016/j.forsciint.2015.03.026.
   PubMed Web of Science ®Google Scholar
• Brunt, T. M., S. Rigter, J. Hoek, N. Vogels, P. Van Dijk, and R. J. Niesink. 2009. An analysis of cocaine powder in the Netherlands: Content and health hazards due to adulterants. Addiction 104 (5):798–805. doi:10.1111/j.1360-0443.2009.02532.x.
   PubMed Web of Science ®Google Scholar
• Chang, A., J. Osterloh, and J. Thomas. 2010. Levamisole: A dangerous new cocaine adulterant. Clinical Pharmacology and Therapeutics 88:408–11. doi:10.1038/clpt.2010.156.
   PubMed Web of Science ®Google Scholar
• Cole, C., L. Jones, J. McVeigh, A. Kicman, Q. Syed, and M. Bellis. 2011. Adulterants in illicit drugs: A review of empirical evidence. Drug Testing and Analysis 3 (2):89–96. doi:10.1002/dta.220.
   PubMed Web of Science ®Google Scholar
• Eiden, C., C. Diot, O. Mathieu, M. Mallaret, and H. Peyrière. 2014. Levamisole-adulterated cocaine: What about in European countries?. Journal of Psychoactive Drugs 46 (5):389–92. doi:10.1080/02791072.2014.959215.
   PubMed Web of Science ®Google Scholar
• EMCDDA. 2016. European drug report 2016: Trends and developments., Lisbon, Portugal: EMCDDA.
   Google Scholar
• Evrard, I., S. Legleye, and A. Cadet-Tairou. 2010. Composition, purity and perceived quality of street cocaine in France. International Journal of Drug Policy 21 (5):399–406. doi:10.1016/j.drugpo.2010.03.004.
   PubMed Web of Science ®Google Scholar
• Gaine, S. P., L. J. Rubin, J. J. Kmetzo, H. I. Palevsky, and T. A. Traill. 2000. Recreational use of aminorex and pulmonary hypertension. Chest 118 (5):1496–97. doi:10.1378/chest.118.5.1496.
   PubMed Web of Science ®Google Scholar
• Graf, J. 2013. Rheumatic manifestations of cocaine use. Current Opinion in Rheumatology 25 (1):50–55. doi:10.1097/BOR.0b013e32835b4449.
   PubMed Web of Science ®Google Scholar
• Hofmaier, T., A. Luf, A. Seddik, T. Stockner, M. Holy, M. Freissmuth, G. F. Ecker, R. Schmid, H. H. Sitte, and O. Kudlacek. 2014. Aminorex, a metabolite of the cocaine adulterant levamisole, exerts amphetamine like actions at monoamine transporters. Neurochemistry International 73:32–41. doi:10.1016/j.neuint.2013.11.010.
   PubMed Web of Science ®Google Scholar
• Indorato, F., G. Romano, and N. Barbera. 2016. Levamisole-adulterated cocaine: Two fatal case reports and evaluation of possible cocaine toxicity potentiation. Forensic Science International 265:103–06. doi:10.1016/j.forsciint.2016.01.005.
   PubMed Web of Science ®Google Scholar
• Karch, S. B., F. P. Busardo, F. Vaiano, F. Portelli, S. Zaami, and E. Bertol. 2016. Levamisole adulterated cocaine and pulmonary vasculitis: Presentation of two lethal cases and brief literature review. Forensic Science International 265:96–102. doi:10.1016/j.forsciint.2016.01.015.
   PubMed Web of Science ®Google Scholar
• Karch, S. B., F. Mari, V. Bartolini, and E. Bertol. 2012. Aminorex poisoning in cocaine abusers. International Journal of Cardiology 158 (3):344–46. doi:10.1016/j.ijcard.2011.06.105.
   PubMed Web of Science ®Google Scholar
• Karch, S. B., F. Vaiano, and E. Bertol. 2015. Levamisole, aminorex, and pulmonary arterial hypertension: A review. Razavi International Journal of Medicine 3 (3):e28277. doi:10.17795/rijm28277.
   Google Scholar
• Khan, T. A., R. Cuchacovich, L. R. Espinoza, S. Lata, N. J. Patel, I. Garcia-Valladares, M. M. Salassi, and C. V. Sanders Jr. 2011. Vasculopathy, hematological, and immune abnormalities associated with levamisole-contaminated cocaine use. Seminars in Arthritis and Rheumatism 41 (3):445–54. doi:10.1016/j.semarthrit.2011.04.010.
   PubMed Web of Science ®Google Scholar
• Lapachinske, S. F., G. G. Okai, A. Dos Santos, A. V. De Bairros, and M. Yonamine. 2015. Analysis of cocaine and its adulterants in drugs for international trafficking seized by the Brazilian Federal Police. Forensic Science International 247:48–53. doi:10.1016/j.forsciint.2014.11.028.
   PubMed Web of Science ®Google Scholar
• Larocque, A., and R. S. Hoffman. 2012. Levamisole in cocaine: Unexpected news from an old acquaintance. Clinical Toxicology 50 (4):231–41. doi:10.3109/15563650.2012.665455.
   PubMed Web of Science ®Google Scholar
• Lynch, K. L., S. S. Dominy, J. Graf, and A. H. Kral. 2011. Detection of levamisole exposure in cocaine users by liquid chromatography-tandem mass spectrometry. Journal of Analytical Toxicology 35 (3):176–78. doi:10.1093/anatox/35.3.176.
   PubMed Web of Science ®Google Scholar
• McGrath, M. M., T. Isakova, H. G. Rennke, A. M. Mottola, K. A. Laliberte, and J. L. Niles. 2011. Contaminated cocaine and antineutrophil cytoplasmic antibody-associated disease. Clinical Journal of the American Society of Nephrology 6 (12):2799–805. doi:10.2215/CJN.03440411.
   PubMed Web of Science ®Google Scholar
• Michaud, K., S. Grabherr, K. Shiferaw, F. Doenz, M. Augsburger, and P. Mangin. 2014. Acute coronary syndrome after levamisole-adultered cocaine abuse. Journal of Forensic and Legal Medicine 21:48–52. doi:10.1016/j.jflm.2013.10.015.
   PubMed Web of Science ®Google Scholar
• Pawlik, E., H. Mahler, B. Hartung, G. Plasser, and T. Daldrup. 2015. Drug-related death: Adulterants from cocaine preparations in lung tissue and blood. Forensic Science International 249:294–303. doi:10.1016/j.forsciint.2015.02.006.
   PubMed Web of Science ®Google Scholar
• Pendergraft, W. F. 3rd, L. C. Herlitz, D. Thornley-Brown, M. Rosner, and J. L. Niles. 2014. Nephrotoxic effects of common and emerging drugs of abuse. Clinical Journal of the American Society of Nephrology 9 (11):1996–2005. doi:10.2215/CJN.00360114.
   PubMed Web of Science ®Google Scholar
• Peters, F. T., O. H. Drummer, and F. Musshoff. 2007. Validation of new methods. Forensic Science International 165 (2–3):216–24. doi:10.1016/j.forsciint.2006.05.021.
   PubMed Web of Science ®Google Scholar